Companies /Industrials

Ingersoll-Rand Inc

NYSE: IR Specialty Industrial Machinery
$77.05
▼ $1.53 (−1.95%) today
Markets closed · 8:11pm ET

Q2 2026 Earnings

Reported Jul 30, 2026, 4:16pm ET · SEC source
$0.86
Beat +4.05%
EPS · est. $0.83
$2.0B
Beat +4.72%
Revenue · est. $2.0B
3 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−6%−3%0+3%Jul 30Jul 31report 4:16pm ETearnings+0.5%+3.1%
−6%−3%0+3%Jul 30Jul 31earnings+0.5%+3.1%
IR +3.1%S&P 500 +0.5%
−6%−3%0+3%Jul 30Jul 31report 4:16pm ETearnings+0.3%+3.1%
−6%−3%0+3%Jul 30Jul 31earnings+0.3%+3.1%
IR +3.1%NASDAQ +0.3%
0+5%+10%Jul 30Aug 7report 4:16pm ETearnings+4.2%+7.9%
0+5%+10%Jul 30Aug 7earnings+4.2%+7.9%
IR +7.9%S&P 500 +4.2%
0+5%+10%Jul 30Aug 7report 4:16pm ETearnings+5.4%+7.9%
0+5%+10%Jul 30Aug 7earnings+5.4%+7.9%
IR +7.9%NASDAQ +5.4%
−1.11%
Day of report
+5.28%
Next session
+4.31%
One week

Did IR Beat Earnings? Q2 2026 Results

Ingersoll Rand Inc. delivered a strong second quarter of 2026, beating Wall Street expectations on both the top and bottom lines as the company's operational framework drove broad-based momentum. The industrial manufacturer posted adjusted EPS of $0.86, ahead of the $0.83 consensus estimate by 4.05%, while revenue of $2.05 billion beat expectations by 4.72% and climbed 8.5% year over year. The standout driver was the Precision and Science Technologies segment, which generated 7% organic order growth including low double-digit Life Sciences gains, and expanded its Adjusted EBITDA margin by 200 basis points to 31.5%. Free cash flow strengthened to $268.90 million from $210.40 million a year ago, and the company returned approximately $248.00 million to shareholders in the quarter. Looking ahead, management updated full-year 2026 guidance to revenue growth of 4.5% to 6.5% and Adjusted EPS of $3.45 to $3.57, noting it expects to finish near the high end of that earnings range, signaling continued confidence in its organic growth trajectory.

Key Takeaways
  • Ingersoll Rand Execution Excellence (IRX) operating framework driving operational performance
  • Strong organic revenue growth of 4.1% overall, with positive growth in all IT&S regions
  • P&ST organic orders up 7%, with low double-digit Life Sciences growth and mid single-digit Precision Technologies growth
  • P&ST Adjusted EBITDA margin expanded 200 basis points to 31.5%
  • Overall compressor orders up low single digits globally with healthy North America activity
  • Free cash flow margin expanded to 13.1% from 11.1% year-over-year

“Our second quarter results reflect strong organic growth and solid Adjusted EPS performance, driven by the strength of our portfolio and the consistent execution by our teams. Order momentum continues to build, reinforcing our confidence in delivering on our full-year commitments as we remain focused on staying agile, and driving durable, long-term growth.”

Ingersoll Rand CEO, on the earnings call

Forward Guidance & Outlook

Ingersoll Rand updated its full-year 2026 guidance: Revenue growth of 4.5% to 6.5% (organic growth of 1% to 3%, currency ~+1%, M&A ~+2.5%); Adjusted EBITDA of $2,130M to $2,190M with corporate costs of ~$170M; Adjusted EPS of $3.45 to $3.57 (expected to finish near the high end of the range) assuming ~22% adjusted tax rate, ~$230M net interest expense, and ~391.5M share count; Free Cash Flow to Adjusted Net Income conversion of ~95% with CAPEX at ~2% of sales. Revenue phasing is expected at 1H 48% / 2H 52%, and Adjusted EBITDA phasing at 1H 46% / 2H 54%.

IR YoY Financials

Q2 2026 vs Q2 2025 · SEC filings Q2 2025 Q2 2026
$0$600.0M$1.2B$1.8B$1.9B$2.0BRevenue$824.9M$862.6MGross Profit$76.4M$380.3MOperating Income$60.9M$258.0MNet Income
$0$600.0M$1.2B$1.8BRevenueGross ProfitOperating IncomeNet Income

IR Revenue by Segment

Industrial Technologies and Services$1.6B+8.7%
Precision and Science Technologies$426.7M+7.7%

Figures from SEC filings and company reports. Not investment advice.